Single-agent anti-PD1 checkpoint inhibitors convey outstanding clinical benefits in a small fraction (∼20%) of patients with advanced hepatocellular carcinoma (aHCC) but the molecular mechanisms determining response are unknown. To fill this gap, we herein analyze the molecular and immune traits of aHCC in patients treated with anti-PD1.

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma / P.K. Haber, F. Castet, M. Torres-Martin, C. Andreu-Oller, M. Puigvehí, M. Miho, P. Radu, J. Dufour, C. Verslype, C. Czauderna, J.U. Marquardt, P.R. Galle, A. Vogel, M. Bathon, T. Meyer, I. Labgaa, A. Digklia, L.R. Roberts, M.A. Mohamed Ali, B. Mínguez, D. Citterio, V. Mazzaferro, F. Finkelmeier, J. Trojan, B. Özdirik, T. Müller, M. Schmelzle, A. Bejjani, M.W. Sung, M.E. Schwartz, R.S. Finn, S. Thung, A. Villanueva, D. Sia, J.M. Llovet. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - (2022). [Epub ahead of print] [10.1053/j.gastro.2022.09.005]

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

V. Mazzaferro;
2022

Abstract

Single-agent anti-PD1 checkpoint inhibitors convey outstanding clinical benefits in a small fraction (∼20%) of patients with advanced hepatocellular carcinoma (aHCC) but the molecular mechanisms determining response are unknown. To fill this gap, we herein analyze the molecular and immune traits of aHCC in patients treated with anti-PD1.
Biomarkers; Hepatocellular Carcinoma; Immunotherapy; Predictors of Response
Settore MED/06 - Oncologia Medica
12-set-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0016508522010393-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 11.55 MB
Formato Adobe PDF
11.55 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/947065
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact